Literature DB >> 6619287

Toxic shock syndrome: modification and comparison of methods for detecting marker proteins in Staphylococcus aureus.

M L Cohen, L M Graves, P S Hayes, R J Gibson, J K Rasheed, J C Feeley.   

Abstract

Development of a new medium and modification of incubation conditions increased production of toxic shock syndrome marker proteins and enabled detection of small volumes of pyrogenic exotoxin C (PEC) by isoelectric focusing and staphylococcal enterotoxin F (SEF) by a newly developed solid-phase radioimmunoassay. The results were compared with those obtained with previously described methods. The results were identical, and all PEC-positive isolates were SEF positive. In a second study of 262 randomly selected Staphylococcus aureus isolates examined by isoelectric focusing and solid-phase radioimmunoassay but grown in fresh beef heart medium, 47 (17.9%) isolates were PEC and SEF positive; however, 9 (3.4%) were PEC positive and SEF negative, and 3 (1.1%) were SEF positive and PEC negative. When grown in buffered beef heart yeast extract medium, six of the previously PEC-positive and SEF-negative isolates were PEC negative. Autoradiographic analysis of selected isolates demonstrated that PEC- and SEF-positive strains bound SEF antitoxin to the protein at isoelectric point 7.2, suggesting that in staphylococci from patients with toxic shock syndrome, PEC and SEF are the same protein. In screening staphylococci for toxic shock syndrome marker proteins, isoelectric focusing to identify PEC may detect false-positive proteins and may be more susceptible to technical variation than immunological methods to detect SEF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6619287      PMCID: PMC270807          DOI: 10.1128/jcm.18.2.372-375.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Toxic shock syndrome: the emerging picture.

Authors:  K N Shands; B B Dan; G P Schmid
Journal:  Ann Intern Med       Date:  1981-02       Impact factor: 25.391

2.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

3.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

4.  In-vitro studies of interactions between tampons and Staphylococcus aureus.

Authors:  C V Broome; P S Hayes; G W Ajello; J C Feeley; R J Gibson; L M Graves; G A Hancock; R L Anderson; A K Highsmith; D C Mackel; N T Hargrett; A L Reingold
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

5.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.

Authors:  K N Shands; G P Schmid; B B Dan; D Blum; R J Guidotti; N T Hargrett; R L Anderson; D L Hill; C V Broome; J D Band; D W Fraser
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

6.  Protein antigens from Staphylococcus aureus strains associated with toxic-shock syndrome.

Authors:  M L Cohen; S Falkow
Journal:  Science       Date:  1981-02-20       Impact factor: 47.728

  6 in total
  13 in total

1.  Latex agglutination test for staphylococcal toxic shock syndrome toxin 1.

Authors:  H Igarashi; H Fujikawa; M Shingaki; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

2.  Imbalanced serum IgG subclass pattern in toxic shock syndrome patients: deficiency of specific IgG1 and IgG4 subclass antibodies to toxic shock syndrome toxin 1.

Authors:  B Christensson; P J Johansson; V A Oxelius
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

Review 3.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

4.  Toxic shock syndrome: chronology of state and federal epidemiologic studies and regulatory decision-making.

Authors:  M E Donawa; G R Schmid; M T Osterholm
Journal:  Public Health Rep       Date:  1984 Jul-Aug       Impact factor: 2.792

5.  Rapid screening assay for toxic shock syndrome toxin production by Staphylococcus aureus.

Authors:  L S Weckbach; M R Thompson; J L Staneck; P F Bonventre
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

6.  The effect of vaginal microbial communities on colonization by Staphylococcus aureus with the gene for toxic shock syndrome toxin 1 (TSST-1): a case-control study.

Authors:  Jacob D Pierson; Melanie A Hansmann; Catherine C Davis; Larry J Forney
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

7.  Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus.

Authors:  M W Reeves; L Pine; J C Feeley; D E Wells
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Enhanced susceptibility of male rabbits to infection with a toxic shock strain of Staphylococcus aureus.

Authors:  G K Best; D F Scott; J M Kling; W F Crowell; J J Kirkland
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

9.  Production of toxic-shock-associated protein(s) in Staphylococcus aureus strains isolated from 1956 through 1982.

Authors:  P S Hayes; L M Graves; J C Feeley; G A Hancock; M L Cohen; A L Reingold; C V Broome; A W Hightower
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

10.  Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model.

Authors:  J K Rasheed; R J Arko; J C Feeley; F W Chandler; C Thornsberry; R J Gibson; M L Cohen; C D Jeffries; C V Broome
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.